Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients
Clinical trial NCT00985426 · COMPLETED
Trial details
- NCT number
- NCT00985426
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 521
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.